Help control your eye pressure and possibly reduce your need for Glaucoma medication with the Hydrus® Microstent.
Location: United States, California, Irvine
Total raised: $120.5M
Investors 8
Funding Rounds 5
Date | Series | Amount | Investors |
10.01.2017 | Series C | $25M | RA Capital... |
13.01.2014 | Series B | $46.5M | - |
20.08.2013 | Series B | $5M | - |
31.01.2013 | Series B | $27M | - |
27.06.2011 | - | $17M | - |
Mentions in press and media 13
Date | Title | Description | Source |
15.09.2021 | Ivantis Announces Settlement of Glaukos Patent Litigation | IRVINE, Calif., Sept. 15, 2021 /PRNewswire/ -- Ivantis, Inc., developer of the novel Hydrus® Micro... | prnewswire... |
17.11.2020 | Hydrus Microstent Receives Highest Designation of Any MIGS D... | IRVINE, Calif., Nov. 17, 2020 /PRNewswire/ -- Ivantis Inc., developer of the novel Hydrus® Microst... | prnewswire... |
10.01.2017 | Term Sheet — Tuesday January 10 | ALL AI EVERYTHING Jocelyn Goldfein has worked on some of Silicon Valley’s most iconic products: She... | fortune.co... |
10.01.2017 | Singapore: EDBI & Vertex Ventures-backed Ivantis closes ... | Premium Ivantis Inc., developer of the Hydrus Microstent device designed to lower eye pressure for ... | dealstreet... |
10.01.2017 | Ivantis Raises $25M in Series C Funding | Ivantis Inc., an Irvine, CA-based developer of a device designed to lower eye pressure for glaucoma ... | finsmes.co... |
09.01.2017 | Ivantis Finds $25M For Microstent Surgery Devices | Irvine-based medical device developer Ivantis, which is developing microstents for minimally invasiv... | socaltech.... |
09.01.2017 | RA Capital Leads $25M Series C for Ivantis | Ivantis Inc., developer of the novel Hydrus™ Microstent device designed to lower eye pressure for gl... | citybizlis... |
13.01.2014 | Ivantis Completes $46.5M Series B Financing | IRVINE, CA, Developer of the novel Hydrus Microstent device designed to lower eye pressure for gla... | vcnewsdail... |
20.08.2013 | Ivantis Raises $5M in Second Close of Series B Financing | Ivantis, an Irvine, California-based developer of a microstent device designed to lower eye pressure... | finsmes.co... |
01.02.2013 | Ivantis reels in $27M Series B round | Wall Street Beat | Ivantis said it raised a $27 million Series B round led by Ascension Health Ventures aimed at fundin... | massdevice... |
Show more